Skip To Main Content
Pratikkumar Patel on Muck Rack

Pratikkumar Patel

As seen in: Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Pratikkumar Patel’s profile

Articles by Pratikkumar Patel

Optimize Data Center Efficiency for AI and HPC Workloads with Power Profiles

|
By Pratikkumar Patel
| NVIDIA Developer Blog
Exponentially growing computational demand is driving power usage higher and pushing data centers to their limits. With facilities power constrained, extracting the most performance per provisioned watt of power is crucial to optimize throughput from a data center. To help users and system administrators extract the most performance out of power-limited data centers, NVIDIA has released data center energy optimized power profiles.
Open in Who Shared Issue with article?

[2510.03872] Datacenter Energy Optimized Power Profiles

|
By Pratikkumar Patel, Ian Karlin, Apoorv Gupta, Pratikkumar Dilipkumar
| arXiv
arXiv:2510.03872 (cs) View PDF Subjects: Distributed, Parallel, and Cluster Computing (cs.DC) Cite as: arXiv:2510.03872 [cs.DC] (or arXiv:2510.03872v1 [cs.DC] for this version) https://doi.org/10.48550/arXiv.2510.03872 Submission history From: Pratikkumar Dilipkumar Patel [ view email] [v1] Sat, 4 Oct 2025 16:49:19 UTC (456 KB) Bibliographic Tools Bibliographic Explorer Toggle Bibliographic Explorer () Connected Papers Toggle Connected Papers (What is Connected Papers?) Litmaps Toggle Litmaps...
Open in Who Shared View Duplicates (458) Issue with article?

STING agonist using LNP inhibits pancreatic cancer growth

|
By Pratikkumar Patel, Umar-Farouk Mamani, Yuhan Guo, Sherin George Shaji
| Dove Medical Press
Introduction Pancreatic cancer is the third leading cause of cancer-related death in the United States.
Open in Who Shared Issue with article?

Impact of Propeptide Cleavage on the Stability and Activity of a Streptococcal Immunomodulatory C5a Peptidase for Biopharmaceutical Development

|
By Vinayakumar Gedi, Francisco Duarte, Pratikkumar Patel, Promita Bhattacharjee
| dx.doi.org
Posttranslational modifications of proteins can impact their therapeutic efficacy, stability, and potential for pharmaceutical development. The Group AC5a peptidase (ScpA) is a multi-domain protein composed of an N-terminal signal peptide, a catalytic domain (including propeptide), three fibronectin domains, and cell membrane-associated domains. It is one of several proteins produced by Group Aknown to cleave components of the human complement system.
Open in Who Shared Issue with article?
Show More